Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate safety, tolerability, pharmacokinetics, and anti-tumor activity of CBI-1214 T cell engager in adults with advanced or metastatic color…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• CBI-1214 T Cell Engager

Snippet

Sponsor: Cartography Biosciences | Conditions: Colorectal Cancer, Colorectal Cancer (CRC) | Phase 1 | Status: RECRUITING